Wall Street Journal
Commercial News
10/17/21
WSJ.com: US Business
Moderna Vaccine for Adolescents Delayed for FDA Review
Moderna asked the Food and Drug Administration in June to expand use of the company?s Covid-19 vaccine to 12-to-17-year-olds, but the agency has held off while it looks into the risk of myocarditis, a rare heart condition. J&J Covid-19 Booster Shot Endorsed by FDA Advisers
A panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the Johnson & Johnson vaccine should get the second dose at least two months later. California Scrambles to Find Electricity to Offset Plant Closures
The state is contending with the coming loss of gas-fired power plants and its last remaining nuclear facility in a planned transition to renewable energy. Three Years After First 737 MAX Crash, Fallout Continues for Boeing and Victims
The indictment of a former technical pilot is first time an individual has faced charges related to the accidents. The company previously reached a $2.5 billion settlement with the government. Today's Tech Founders Don't Just Own the Company. They're Also Getting Huge Pay Packages.
Startup creators once tended to take little or no remuneration as CEOs. Now, some are getting giant stock awards, making them among America?s best-compensated corporate chiefs. Inflation Sets Off Alarms Around the World
More than a dozen central banks have raised interest rates but two that haven?t are those that loom largest over the global economy: the Federal Reserve and the European Central Bank. Largest Cities Had Some of the Lowest U.S. Inflation Rates
New York City, Los Angeles and Chicago were below the national level in September while rural areas grappled with increases in gasoline and vehicle prices. |
